MedTrace Logo

Dextroamphetamine-Cocaine Behavioral Intervention - 5

NCT00000308 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to examine dextroamphetamine-cocaine behavioral intervention in cocaine dependent patients.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Dextroamphetamine

15 mg of d-amphetamine for first 8 weeks of study and 30 mg for the second 8 weeks

DRUG

D-amphetamine

15 mg of d-amphetamine for first 8 weeks of study and 30 mg for the second 8 weeks

DRUG

placebo

placebo

Sponsors & Collaborators

  • University of Texas

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • John Grabowski, Ph.D. · University of Texas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-09-30
Primary Completion
2000-09-30
Completion
2000-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000308 on ClinicalTrials.gov